Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Effects of an ACWR-Guided Load Management Intervention on Time-Loss Injury Incidence in Chinese Elite Youth Footballers: A Cluster Randomised Controlled Trial (ACWR Injury)

22 de julio de 2026 actualizado por: Jun Li, Xinyang Agriculture and Forestry University
This cluster-randomised controlled trial aims to evaluate whether a multi-component load management intervention-incorporating real-time acute:chronic workload ratio (ACWR) feedback, automated alerts, coach education, and structured load adjustment protocols-reduces time-loss injury incidence in Chinese elite mixed-gender adolescent football players compared with routine training practices.

Descripción general del estudio

Estado

Aún no reclutando

Intervención / Tratamiento

Descripción detallada

Background: Injury prevention in elite youth football is a public health and performance priority. Approximately two-thirds of players sustain at least one time-loss injury annually, with lower extremity injuries predominating. The acute:chronic workload ratio (ACWR) is widely used in sport science as a practical decision-support tool, yet experimental evidence for its effectiveness in reducing injury incidence remains limited and conflicting, particularly in Asian adolescent populations.

Objectives: This cluster-randomised controlled trial evaluates whether a multi-component ACWR-guided load management intervention reduces time-loss injury incidence in Chinese elite youth football players compared with routine practice.

Study Design: A prospective, two-arm, parallel-group, cluster-randomised controlled trial with 1:1 allocation, stratified by age group (U15/U17/U19).

Participants: Twenty-eight elite youth football teams (U15-U19, n=774, 45.2% female) from 28 academies in Henan Province.

Intervention: The intervention comprises real-time ACWR feedback, automated alerts for values outside the 0.8-1.3 range, coach education workshops, and structured load-adjustment protocols. Control teams follow routine practice without ACWR-derived feedback.

Primary Outcome: Time-loss injury incidence rate per 1000 athlete-exposure hours.

Secondary Outcomes: (1) Severe injury incidence (≥28 days lost); (2) Injury burden (days lost per 1000 h); (3) Proportion of lower-extremity injuries; (4) Proportion of non-contact injuries.

Sample Size: 28 teams (14 per arm) with 774 players (median 27 per team, range 22-31), providing 80% power to detect a 25% reduction in injury incidence (IRR=0.75) with α=0.05 and ICC=0.05.

Statistical Analysis: Mixed-effects Poisson regression with ICC adjustment, Fine-Gray competing risk models, shared frailty Cox models, Kaplan-Meier survival analysis, and E-value sensitivity analysis.

Ethics: The study protocol was approved by the Xinyang Agriculture and Forestry University Ethics Committee (XYAFUAE2024021). Written informed consent was obtained from all participants and their parents/legal guardians.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

847

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto

Acepta Voluntarios Saludables

Sí

Descripción

Inclusion Criteria:

  • Age 13-19 years Member of a participating U15, U17, or U19 team No injury precluding full participation at enrolment Provided written informed consent (parental consent for minors)

Exclusion Criteria:

  • Injury precluding full participation at enrolment Failure to provide informed consent Age outside 13-19 years

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Comparador activo: ACWR Intervention vs Control Trial
Coaches in this group will plan and adjust all training sessions based on published Acute:Chronic Workload Ratio (ACWR) load management principles. Player training load data will be monitored using a commercially available athlete management system. The intervention will be implemented for the duration of the complete season. The ACWR will be used to guide training prescription, with the goal of managing the players' acute and chronic workloads to reduce injury risk

Intervention teams implement a structured ACWR-guided load management protocol for the entire season. The protocol comprises four components:

Component 1 - Load Monitoring: After each training session and match, players rate perceived exertion on the Borg CR-10 scale. Session-RPE (sRPE) is calculated as duration (minutes) × RPE score. Data are recorded using a dedicated mobile application (CoachMe v3.2). Research staff provide technical support and weekly reminders.

Component 2 - Weekly ACWR Reports: The research team generates weekly ACWR reports for each player. Reports are emailed to head coaches each Monday morning, covering the preceding week's data.

Component 3-Automated Alerts and Load-Adjustment Recommendations: Coaches receive automated alerts when a player's ACWR falls below 0.8 or exceeds 1.3. When ACWR < 0.8, a progressive increase in training load (10-20% weekly) is suggested. When ACWR > 1.3, coaches are instructed to implement a 10-20% load reduction at the next session,

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Time-loss injury incidence rate per 1000 athlete-exposure hours.
Periodo de tiempo: From enrolment to the end of the 10-month competitive season
Definition: Consistent with the football injury consensus statement, a time-loss injury is defined as any physical impairment sustained during structured football training or competitive matches that prevents a player from full participation in subsequent training sessions or matches. Injuries occurring outside football activities are not recorded.
From enrolment to the end of the 10-month competitive season

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de julio de 2026

Finalización primaria (Estimado)

30 de abril de 2027

Finalización del estudio (Estimado)

30 de abril de 2027

Fechas de registro del estudio

Enviado por primera vez

20 de julio de 2026

Primero enviado que cumplió con los criterios de control de calidad

22 de julio de 2026

Publicado por primera vez (Actual)

27 de julio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

27 de julio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

22 de julio de 2026

Última verificación

1 de julio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • XYAFUAE2026021

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

All of the individual participant data collected during the trial, after deidentification. This will include, but is not limited to: baseline demographic and anthropometric data, training load metrics (e.g., acute:chronic workload ratio [ACWR] and its components), time-loss injury incidence and severity data, and exposure hours.

Additional documents to be made available: Study Protocol, Statistical Analysis Plan (SAP), and Informed Consent Form (ICF).

Time frame: Data will be available beginning 9 months and ending 36 months following publication of the primary results.

Access criteria: Data will be made available to researchers who provide a methodologically sound proposal for the purpose of achieving the aims in the approved proposal. Proposals should be directed to the Principal Investigator. To gain access, data requesters will need to sign a data access agreement

Marco de tiempo para compartir IPD

Beginning 9 months and ending 36 months following article publication.

Criterios de acceso compartido de IPD

Data will be shared with researchers who provide a methodologically sound proposal, to achieve the aims in the approved proposal. Proposals should be directed to the Principal Investigator (PI). To gain access, data requestors will need to sign a data access agreement.

Tipo de información de apoyo para compartir IPD

  • PROTOCOLO DE ESTUDIO
  • CIF

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir